Hu14 18-Interleukin-2 Fusion Protein
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Response Modifier ->
Immunoconjugate -> Hu14 18-Interleukin-2 Fusion Protein
Hu14 18-Interleukin-2 Fusion Protein Definition
A recombinant protein consisting of the hu14.18 monoclonal antibody fused to the cytokine interleukin-2 (IL2) with potential antineoplastic activity. The monoclonal antibody portion of the hu14.18-IL2 fusion protein binds to tumor cells expressing the GD2 antigen (melanoma, neuroblastoma and certain other tumors); the Fc component of the fusion protein antibody moiety and natural killer (NK) cells mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cellular cytotoxicity (CDCC) towards GD2-expressing tumor cells. The localized IL2 moiety of the fusion protein stimulates NK and T-cell antitumor cellular immune responses.
Hu14 18-Interleukin-2 Fusion Protein Synonyms
Hu14.18-IL2 Fusion Protein, EMD 273063, Hu 14.18/IL - 2 Fusion Protein, Hu14.18-IL2, hu14.18-interleukin-2 fusion protein
Terms in Hu14 18-Interleukin-2 Fusion Protein category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.